| Product NDC: | 63323-269 |
| Proprietary Name: | Diprivan |
| Non Proprietary Name: | PROPOFOL |
| Active Ingredient(s): | 10 mg/mL & nbsp; PROPOFOL |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, EMULSION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 63323-269 |
| Labeler Name: | Fresenius Kabi USA, LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA019627 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20091113 |
| Package NDC: | 63323-269-94 |
| Package Description: | 10 VIAL in 1 BOX (63323-269-94) > 20 mL in 1 VIAL |
| NDC Code | 63323-269-94 |
| Proprietary Name | Diprivan |
| Package Description | 10 VIAL in 1 BOX (63323-269-94) > 20 mL in 1 VIAL |
| Product NDC | 63323-269 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | PROPOFOL |
| Dosage Form Name | INJECTION, EMULSION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20091113 |
| Marketing Category Name | NDA |
| Labeler Name | Fresenius Kabi USA, LLC |
| Substance Name | PROPOFOL |
| Strength Number | 10 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | General Anesthesia [PE],General Anesthetic [EPC] |